TargetMol

B 669

Product Code:
 
TAR-T26732
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26732-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26732-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26732-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
B 669 has antibacterial activity.
CAS:
78182-92-0
Formula:
C30H28N4
Molecular Weight:
444.582
Purity:
0.98
SMILES:
C1CCC(CC1)N=c1cc2n(-c3ccccc3)c3ccccc3nc2cc1Nc1ccccc1

References

1. Plass W, Pohlmann A, Yozgatli HP. N-Salicylidenehydrazides as versatile tridentate ligands for dioxovanadium(V) complexes. J Inorg Biochem. 2000 May 30;80(1-2):181-3. PubMed PMID: 10885484. 2. Steel HC, Matlola NM, Anderson R. Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 activity. J Antimicrob Chemother. 1999 Aug;44(2):209-16. PubMed PMID: 10473227. 3. Van Rensburg CE, Joon? G, Anderson R. Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669. Cancer Lett. 1998 May 15;127(1-2):107-12. PubMed PMID: 9619865. 4. Van Rensburg CE, Anderson R, Joon? G, Myer MS, O'Sullivan JF. Novel tetramethylpiperidine-substituted phenazines are potent inhibitors of P-glycoprotein activity in a multidrug resistant cancer cell line. Anticancer Drugs. 1997 Aug;8(7):708-13. PubMed PMID: 9311448.